NUTRA PHARMA (NPHC) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 22 111 sessions, August 27, 2025 to September 2, 2026
- Largest daily move
- +200% close of January 2, 2026
- 1-year change
- +0% closing prices, August 27, 2025 to September 2, 2026
- 5-year change
- -96.4% closing prices, September 2, 2021 to September 2, 2026
Company Description
NUTRA PHARMA (OTC: NPHC) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $716.0K.
NPHC has gained 0.0% over the past year. The last closing price was $0.0001.
For FY2025, NUTRA PHARMA reported revenue of $258K with net income of -$2.0M and diluted earnings per share of $0.00. The company operates at a net profit margin of -794.8%.
This page collects what Stock Titan holds for NPHC, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
NUTRA PHARMA (NPHC) closed at $0.0001 on September 2, 2026. Over the past 12 months, the price has gained 0.0%.
NPHC Metrics & Rankings
Price returns through September 2, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
NUTRA PHARMA has 7 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 2 with negative movement. View all NPHC news →
SEC Filings
NUTRA PHARMA has filed 5 recent SEC filings, including 1 Form 3, 1 Form 4, 1 Form 8-K, 1 Form SCHEDULE 13D. The most recent filing was submitted on September 2, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all NPHC SEC filings →
Financial Highlights
NUTRA PHARMA generated $258K in revenue in FY2025, retaining a 76.3% gross margin, operating income reached -$1.5M (-567.6% operating margin), and net income was -$2.0M, reflecting a -794.8% net profit margin. Diluted earnings per share stood at $0.00. The company generated -$1.2M in operating cash flow. With a current ratio of 0.03, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
NPHC Company Profile & Sector Positioning
NUTRA PHARMA (NPHC) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing NPHC often look at related companies in the same sector, including KAYA HOLDINGS INC (KAYS), PHARMADRUG INC (LMLLF), MAPLE LEAF GREEN WRLD INC (MGWFF), ADASTRA HOLDINGS LTD (XTXXF), and CANN AMERICAN CORP (CNNA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NPHC's relative position within its industry.